Literature DB >> 4527190

Interrelations in the oxidative metabolism of free fatty acids, glucose, and glycerol in normal and hyperlipemic patients. A compartmental model.

C L Malmendier, C Delcroix, M Berman.   

Abstract

Palmitate, glucose, and glycerol oxidation to CO(2) have been investigated in the fasted state in ten normal subjects and nine patients (six hyperlipoproteinemias, one xanthomatosis, and two glycogenosis) after intravenous injection of [1-(14)C]palmitate, [1-(14)C]glucose, or [1-(14)C]glycerol in tracer amounts. The specific activities and concentrations of plasma palmitate, glycerol, or glucose and expired CO(2) were measured at various intervals after the injection for a period of 24 h. All the studies were analyzed in terms of a multicompartment model describing the structure for each of the subsystems, the transfer of carbon label between subsystems, and the oxidation to CO(2). A bicarbonate subsystem was also included in the model to account for its role in shaping the CO(2) curves. All the CO(2) activity following a palmitate injection could be accounted for by a direct oxidative pathway from plasm FFA with the addition of a 20-min delay compartment. The same also applied to glucose, except that the delay compartment had a mean time of about 150 min. Only about a third of the injected glycerol was directly oxidized to CO(2) from plasma; the delay time was about 4 min. Most of the remainder was converted to glucose. In normals about 45% of the FFA is oxidized to CO(2) directly. This constitutes about 30% of the total CO(2) output. In hyperlipemia the CO(2) output is nearly unchanged and the contribution from FFA is nearly the same. There is a considerable increase (factor of 2), however, in FFA mobilization, most of which is probably diverted to triglyceride synthesis. The glucose and glycerol subsystems are roughly the same in normals and hyperlipemics. About 50% of glucose is oxidized by the direct pathways which accounts for about 35% of the CO(2) output. Glycerol accounts for only 1.5% of the CO(2) produced. Major changes occurred in the glycerol and glucose subsystems in glycogenosis. The changes are consistent with the known deficiency in glucose-6-phosphatase in this disorder. There is a considerable reduction (factor of 2 or more) in the release of glucose to plasma (gluconeogenesis) and in the conversion of glycerol to glucose. Despite the integration of the kinetics of the glucose, glycerol, and FFA subsystems over a 24-h period, 36% of the CO(2) production was still unaccounted for in normals and 50% in hyperlipemics. Thus, some of the carbon must wind up in very slowly turning-over pools which supply CO(2) through subsystems not covered in these studies (triglycerides, glycogen, amino acids, etc.). All the modeling was carried out with the aid of the SAAM25 computer program.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4527190      PMCID: PMC301574          DOI: 10.1172/JCI107782

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Studies of the metabolism and distribution of albumin with autologous I131-albumin in healthy men.

Authors:  Y TAKEDA; E B REEVE
Journal:  J Lab Clin Med       Date:  1963-02

2.  The incorporation of C14 from uniformly labeled glucose into plasma triglycerides in normals and hyperglyceridemics.

Authors:  M FINE; G MICHAELS; S SHAH; B CHAI; G FUKAYAMA; L KINSELL
Journal:  Metabolism       Date:  1962-08       Impact factor: 8.694

3.  C14 studies in carbohydrate metabolism. IV. Characteristics of bicarbonate pool system in the rat.

Authors:  R A SHIPLEY; N BAKER; G E INCEFY; R E CLARK
Journal:  Am J Physiol       Date:  1959-07

4.  [Enzymic method for the determination of glycerin].

Authors:  O WIELAND
Journal:  Biochem Z       Date:  1957

5.  C14 studies in carbohydrate metabolism. I. The oxidation of glucose in normal human subjects.

Authors:  N BAKER; W W SHREEVE; R A SHIPLEY; G E INCEFY; M MILLER
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

Review 6.  The glycogenoses: von Gierke's disease, acid maltase deficiency, and liver glycogen phosphorylase deficiency.

Authors:  R A Field
Journal:  Am J Clin Pathol       Date:  1968-07       Impact factor: 2.493

7.  Insulin, free fatty acids, and stimulation of hepatic gluconeogenesis during fasting.

Authors:  R J Schimmel; E Knobil
Journal:  Am J Physiol       Date:  1970-06

8.  The metabolism of albumin-bound C14-labeled unesterified fatty acids in normal human subjects.

Authors:  D S FREDRICKSON; R S GORDON
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

9.  Kinetic studies of plasma free fatty acid and triglyceride metabolism in man.

Authors:  R P Eaton; M Berman; D Steinberg
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

10.  Production of C14O2 from 1- and 2-C14-acetate by human subjects in various metabolic states.

Authors:  W W SHREEVE; A R HENNES; R SCHWARTZ
Journal:  Metabolism       Date:  1959-09       Impact factor: 8.694

View more
  7 in total

1.  Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus.

Authors:  N Nurjhan; A Consoli; J Gerich
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

2.  Fuel homeostasis in the harbor seal during submerged swimming.

Authors:  R W Davis; M A Castellini; T M Williams; G L Kooyman
Journal:  J Comp Physiol B       Date:  1991       Impact factor: 2.200

3.  A multicompartmental model of fluid-phase endocytosis in rabbit liver parenchymal cells.

Authors:  R Blomhoff; M S Nenseter; M H Green; T Berg
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

4.  Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects.

Authors:  L A Zech; S M Grundy; D Steinberg; M Berman
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

5.  Glucose and free fatty acid turnover in normal subjects and in diabetic patients before and after insulin treatment.

Authors:  S E Hall; J Saunders; P H Sönksen
Journal:  Diabetologia       Date:  1979-05       Impact factor: 10.122

6.  The effect of an antilipolytic agent (acipimox) on the insulin resistance of lipid and glucose metabolism in hypertriglyceridaemic patients.

Authors:  C Saloranta; L Groop; A Ekstrand; A Franssila-Kallunki; M R Taskinen
Journal:  Acta Diabetol       Date:  1994-04       Impact factor: 4.280

7.  Pathway of free fatty acid oxidation in human subjects. Implications for tracer studies.

Authors:  L S Sidossis; A R Coggan; A Gastaldelli; R R Wolfe
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.